RA-2 is a negative gating modulator of KCa2/3 channels (IC50 = 17 nM); it inhibits bradykinin-induced endothelium-derived hyperpolarization (EDH)-type relaxation in U46619-precontracted rings; it aids in elucidating the physiological and pathological roles of KCa2/3 channels in the vasculature, central nervous system, and inflammatory processes.